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Connective tissue growth factor in tubulointerstitial injury of Diabetic nephropathy is the most prevalent cause of
diabetic nephropathy. chronic renal failure and end-stage renal disease in the
Background. Chronic interstitial fibrosis, which follows the United States and the Western world. The onset andonset of glomerular proteinuria, importantly contributes to
progression of renal failure in diabetic nephropathy areprogressive renal failure in diabetic nephropathy. The present
closely associated and correlate with (and are perhapsstudies examine the potential role of tubular connective tissue
growth factor (CTGF). causally linked to) progressive interstitial fibrosis [1].
Methods. The expression of CTGF was examined in rats Chronic interstitial injury follows the onset of glomerular
with diabetic nephropathy. Regulation and actions of CTGF proteinuria. Previous experimental observations fromwere studied in in vitro cell culture models.
this laboratory indicated a role for the glomerular ultra-Results. CTGF mRNA levels were increased in the renal
cortex of rats with streptozotocin-induced diabetes compared filtration of bioactive growth factors [transforming growth
with controls. Immunohistology indicated that CTGF was ex- factor- (TGF-), hepatocyte growth factor (HGF), and
pressed in renal cortex of diabetic rats, in contrast to controls insulin-like growth factor-I (IGF-I)] in “activating” and
in some tubular cross-sections, particularly dilated-appearing
perhaps transforming tubular cells through specific re-proximal tubules, in which it tended to colocalize with insulin-
ceptors on the apical tubular cell surface [2–4]. Thislike growth factor-I (IGF-I). Glomerular ultrafiltrate from dia-
betic rats, which contained bioactive transforming growth fac- causes tubular cells to express increased amounts of ex-
tor- (TGF-) and hepatocyte growth factor (HGF), induced tracellular matrix (ECM) proteins as well as chemokines
increased CTGF expression in tubular cells. TGF-1 and, to a and cytokines.lesser extent, HGF also raised CTGF expression in cultured
Connective tissue growth factor (CTGF), a cysteine-proximal tubular cells. In contrast, high glucose (25 mmol/L)
rich, heparin-binding 38 kD growth factor protein [5], isdid not increase the secretion of CTGF. In cultured tubular
cells, rhCTGF moderately increased fibronectin but not colla- expressed in mesenchymal cells such as fibroblasts and
gen (Col) type I and type III expression. In NRK-49F renal smooth muscle cells [6]. In these latter cell types CTGF
interstitial fibroblasts, CTGF raised Col 1III and thrombo- is up-regulated by TGF-, which acts through a distinctspondin-1 levels. CTGF has an IGF-binding domain and binds
element in the promoter region of the CTGF gene [6–8].to IGF-I. In NRK-49F cells, IGF-I increased the activity of
CTGF towards the expression of Col 1III. In fibroblasts, CTGF may mediate some of the TGF-–
Conclusions. CTGF is expressed and regulated downstream induced increase in ECM protein production by auto-
from TGF- and HGF in proximal tubular cells, is induced by crine modes of action [9, 10]. In mesangial cells, whichdiabetic rat glomerular ultrafiltrate, and has moderate profi-
genetically are mostly smooth muscle cell related, TGF-brogenic activity in tubular cells and renal interstitial fibro-
also induces CTGF. Moreover, incubation of these cellsblasts, where its activity is IGF-I dependent. By these means,
CTGF may act downstream of TGF- and HGF and may with high glucose increases CTGF expression by TGF-–
contribute to chronic tubulointerstitial fibrosis in diabetic ne- dependent mechanisms [11, 12]. In contrast to cells of
phropathy.
mesenchymal derivation, in epithelial cells, CTGF is
thought to be TGF- independent [8].
Connective tissue growth factor has a conserved IGF-
binding motif near the amino terminus [13, 14] and binds
IGF-I and IGF-II, although with much lesser affinityKey words: collagen, thrombospondin, IGF-I, chronic renal failure,
end-stage renal disease, progressive interstitial nephritis. compared with the six classic IGF-binding proteins
[13, 14]. This interaction between IGFs and CTGF mayReceived for publication August 15, 2000
result in functional collaboration between the twoand in revised form December 1, 2000
Accepted for publication January 24, 2001 growth factor proteins.
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hypothesis that CTGF is also expressed in renal proximal lis, MN, USA), rhHGF (N 6, 1 nmol/L; R&D Systems),
tubular cells and is regulated by TGF- and HGF (which or high glucose (25 mmol/L). Incubations of MCT cells
are both present in proximal tubular fluid in proteinuric with high-glucose medium were also performed in the
glomerular diseases), is induced by high glucose, and presence of neutralizing anti–TGF- antibody (R&D Sys-
increases the expression of ECM proteins in proximal tems) or nonimmune IgG (control). After 24 hours, total
tubular cells and renal interstitial fibroblasts. Moreover, RNA was extracted from each well as described pre-
IGF-I may increase CTGF’s activity. By these means, viously in this article. Expression of collagen (Col) 2I,
CTGF could contribute to tubulointerstitial pathology Col 1III and fibronectin was examined by RT-PCR as
in progressive diabetic nephropathy. described later in this article. In separate experiments,
MCT cells were incubated with control medium or me-
dium containing rhTGF-1 (1 nmol/L) in the presenceMETHODS
or absence of heparin (25 g/mL). Heparin avidly binds
Animal model CTGF, and the difference between CTGF levels in media
Diabetes mellitus was induced in male Sprague-Daw- in the presence compared with the absence of heparin
ley rats with a single intravenous injection of streptozo- is a measure for cell surface, ECM, and receptor associa-
tocin (85 mg/kg), as had been reported previously from tion of autocrine CTGF. After incubation for 48 hours,
this laboratory [2, 3]. Rats were given daily subcutaneous CTGF levels in media were assessed by Western blot
insulin to maintain serum glucose levels at 300 to 350 analysis as described later in this article.
mg/dL. At 24 to 30 weeks of diabetes, early proximal High glucose may increase the expression of CTGF
tubular fluid was collected intensively by nephron micro- indirectly through elevating TGF- levels, and this may
puncture and stored under oil at –70C for in vitro studies require prolonged incubation. Thus, separate studies
[2, 3]. Coronal sections from diabetic and control rat were performed in MCT cells, which were incubated with
kidneys (1 mm) were obtained. The cortex was dis- high glucose (25 mmol/L) for 72 hours in the presence
sected, and total RNA was extracted with RNA-Stat-60 or absence of neutralizing anti–TGF- antibodies (2.5
reagent using the methods provided by the manufacturer g/mL; R&D Systems, N  6 each). In these studies,
(Tel Test Inc., Friendswood, TX, USA). Separate sec- mRNA levels for TGF-1 and CTGF were measured
tions were fixed with performaldehyde and paraffin em- by quantitative RT-PCR. Moreover, CTGF and TGF-
bedded for immunohistological studies. protein levels were measured in conditioned media by
Western blot analysis and quantitative bioassay, respec-Cell culture models
tively.
In vitro studies were performed in cultured proximal
To examine whether CTGF raises the expression of
tubular cells originally derived from microdissected S3-
ECM proteins in tubular cells, serum-deprived MCTsegments of mouse proximal convoluted tubules (MCT
cells in six-well plates were incubated for 24 to 48 hourscells) [15] and in rat renal interstitial fibroblasts (NRK-
in the presence or absence of rhCTGF (1 nmol/L; N 49F cells; ATCC, Rockville, MD, USA). Both cell lines
6 each; gift from Fibrogen, South San Francisco, CA,were grown in Dulbecco’s modified Eagle’s medium
USA). Total RNA was extracted to measure RNA levels(DMEM)/F-12 medium containing 10% fetal calf serum
for Col 2I, Col 1III, and fibronectin by RT-PCR.(FCS). Prior to use, the cells were incubated in serum-
free medium containing 0.5% bovine serum albumin Experiments in NRK-49F renal interstitial fibroblasts
(BSA) for 24 hours.
Tubular cell-derived CTGF may act by autocrine
modes, but its primary target cell may be renal interstitialExperiments in mouse proximal tubular cells
fibroblasts. Hence, the effects of CTGF on ECM proteinTo examine the effects of diabetic rat glomerular ultra-
expression were also examined in NRK-49F renal inter-filtrate on tubular cell CTGF expression, MCT cells were
stitial fibroblasts. Moreover, studies were performed togrown to confluence in 96-well plates and were serum
examine whether IGF-I further raises the activity ofdeprived for 24 hours. Cells were then incubated for 24
CTGF toward ECM-protein expression. NRK-49F cellshours with 1:5 diluted, pooled tubular fluid in serum-
were incubated with serum-free medium (0.5% BSA) orfree medium (25 L/well, N  4). Total RNA was ex-
medium containing 0.25% FCS in the presence or ab-tracted, and CTGF mRNA levels were measured by
sence of rhCTGF at low (50 pmol/L) or higher (1 nmol/L)reverse transcription-polymerase chain reaction (RT-
concentrations (N  6 each). In additional experiments,PCR) as described later in this article.
cells were coincubated with rhIGF-I (gift from ChironIn separate experiments, MCT cells were grown and
Corp., South San Francisco, CA, USA) and rhCTGF, bothgrowth arrested in six-well plates. Cells were incubated in
at 1 nmol/L, or with each of the two growth factors alonethe absence (control) or presence of recombinant human
(rh) TGF-1 (N 6, 1 nmol/L; R&D Systems, Minneapo- (N 6 each). Total RNA was extracted for the measure-
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Table 1. Primers used in the reverse transciption-polymerase chain reaction assays
Template Sense primer Antisense primer
Murine Col 2I 5-TGTTCGTGGTTCTCAGGGTAG-3 5-TTGTCGTAGCAGGGTTCTTTC-3
Murine Col 1III 5-CGAGGTAACAGAGGTGAAAGA-3 5-AACCCAGTATTCTCCGCTCTT-3
Murine fibronectin 5-TTTTGACAACGGGAAGCATTATCAGATAA-3 5-TGATCAAAACATTTCTCAGCTATTGG-3
Mouse/rat CTGF 5-GAGCTTTCTGGCTGCACC-3 5-TCTCCGTACATCTTCCTG-3
Mouse TGF-1 5-ATACAGGGCTTTCGATTCAGC-3 5-GTCCAGGCTCCAAATATAGG-3
Mouse GAPDH 5-CCATGGAGAAGGCCGGGG-3 5-CAAAGTTGTCATGGATGACC-3
Rat GAPDH 5-GACAAGATGGTGAAGGTCGG-3 5-CATGGACTGTGGTCATGAGC-3
ment of Col 2I, Col 1III, and fibronectin mRNA levels Col 2I, Col 1III, and fibronectin were measured by
RT-PCR (N  6 each).by quantitative RT-PCR.
Endogenous overexpression of CTGF RT-PCR for CTGF, TGF-1, Col 2I,
Col 1III, and fibronectinin NRK-49F cells
The activity of CTGF toward ECM protein expression Random primed first-strand cDNA was synthesized
from RNA in each sample using a commercially availablemay be different in cells that endogenously express this
growth factor at increased rates as compared with exoge- kit and the manufacturer’s instructions (Boehringer
Mannheim/Roche, Indianapolis, IN, USA). Aliquots ofnous exposure with recombinant CTGF. Moreover, the
activity of recombinant CTGF may differ between cDNA were then amplified by PCR using specific prim-
ers (Table 1). In some assays, GAPDH mRNA was usedrhCTGFs that are expressed in different cell systems
due to post-translational processing and folding. Hence, as control. In the PCR assays for TGF-1, Col 1III, and
some of the CTGF RT-PCR assays, parallel amplifica-additional experiments were performed in cultured
NRK-49F renal fibroblasts, which were infected with an tion of 18S ribosomal cDNA in the same tube served
adenoCTGF construct that was kindly provided by Dr. as an internal control using a commercial primer and
George Martin (Fibrogen Inc.), and had been custom competimer reagent (Ambion, Austin, TX, USA). For
made (Quantum Biotechnologies, Montreal, Quebec, each specific assay, PCR conditions were optimized with
Canada) using the pQBI-AdCMV5-IRES-GFP vector respect to template cDNA per tube, MgCl2 concentra-
for the recombination of the CTGF cDNA into replica- tion, temperatures, and number of cycles. PCR products
tion deficient adenovirus. In the adenovirus vector, the were electrophoresed in 4% agarose gels containing 0.5
CTGF gene is under control of a standard cytomegalovi- g/mL of ethidium bromide. Resolved bands were pho-
rus (CMV) promoter. tographed under ultraviolet light with Polaroid negative
Confluent cells in six-well plates were infected at a film (Polaroid, Cambridge, MA, USA). Bands were
multiplicity of infection (MOI) of approximately 500 vi- scanned by densitometry, and densitometric units were
rus particles per cell in 0.5 mL medium for two hours. expressed as ratio to the 18S ribosomal RNA or GAPDH
This MOI had been found to be optimal in pilot studies mRNA in the same sample. Results were expressed as
using MOIs between 1 and 1000. An additional 1.5 mL percentage of mean control.
of medium was then added to each well, and incubations
CTGF Western blot analysiswere continued for a total of 48 hours. Cells were serum
starved for 24 hours and incubated in the presence or Heparin-binding proteins were precipitated from me-
dia with heparin-sepharose CL-6B [1:1 in phosphate-absence of rhIGF-I (50 pmol/L). For comparison, non-
infected cells were treated in parallel and also incubated buffered saline (PBS), 25 L/mL; Pharmacia, Piscata-
way, NJ, USA], and tubes were rotated end over end atwith or without rhIGF-I.
Infection efficiency was examined in aliquot wells by 4C for four hours. After centrifugation, precipitates
were washed three times with ice-cold PBS and takenexpression of green fluorescent protein (GFP), which
was expressed by approximately 60 to 80% of cells, as up in nonreducing sample buffer [125 mmol/L Tris-HCl,
pH. 6.8, 4% sodium dodecyl sulfate (SDS), 20% glycerol,observed by flow cytometry and cell sorting using a FACS-
Calibur cell sorter (Becton-Dickinson, Franklin Lakes, 0.01% bromophenol blue], boiled for three minutes, and
electrophoresed in 15% SDS-polyacrylamide gels. Sepa-NJ, USA) or epifluorescence microscopy, respectively,
and was not affected by coincubation with rhIGF-I. rated proteins were electroblotted onto nitrocellulose.
Membranes were blocked in 5% BSA in TBS (50At the end of the incubation, media were obtained
for assessment of CTGF and thrombospondin-1 (TSP-1) mmol/L Tris-HCl, 150 mmol/L NaCl, pH. 7.4) and then
incubated with chicken anti-CTGF (0.5 g/mL; gift fromby Western blot analysis. RNA was extracted from the
cells in each well, and mRNA levels encoding CTGF, Fibrogen) in TTBS (TBS, 0.2% Tween-20) containing
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Fig. 2. Immunohistology of CTGF (left panels) and IGF-I (right panel)
in diabetic rat renal cortex at 30 weeks. CTGF is expressed in some
otherwise normal-appearing proximal tubules (arrow head), and both
CTGF and IGF-I are colocalized in dilated proximal tubules.
by Dr. Dan Rifkin [16]) as previously described from
this laboratory [3, 4].
Immunohistology for IGF-I and CTGF
Deparafinized 5 m coronal kidney sections were
quenched, blocked, and incubated with anti–IGF-I (SantaFig. 1. Steady-state connective tissue growth factor (CTGF) mRNA
levels in renal cortex in rats after 24 to 30 weeks of diabetes mellitus Cruz Biotechnology, Santa Cruz, CA, USA) or anti-
(DM) and in control animals. *P  0.05 compared with control. CTGF (rabbit polyclonal antibody pAB839; gift from Dr.
George Martin, Fibrogen), biotinylated second antibody,
and visualized with streptavidin-HRPO and a substrate
3% BSA for one hour. Membranes were washed exten- reaction. As a negative control, primary antibody was
sively and then incubated with HRPO-rabbit anti-chicken replaced with nonimmune serum. Sections were lightly
IgG (Zymed, South San Francisco, CA, USA), 1:5000 counterstained with hematoxylin.
in TTBS containing 5% BSA. After further washes in
Statistical analysisTTBS, bands were visualized by chemiluminescence us-
ing a commercially available reagent and the manufactur- Data are expressed as mean SE. Comparisons of two
er’s instructions (Amersham, Arlington Heights, IL, USA), groups were made by t test. Multiple group comparisons
captured on x-ray film, and scanned by densitometry. were made by analysis of variance (ANOVA) and New-
Results are expressed in percentage of mean control. man–Keuls multicomparison test. P  0.05 was pre-
sumed to indicate significance of differences.
TSP-1 Western blot analysis
Heparin-sepharose–precipitated proteins were elec-
RESULTStrophoresed under reducing conditions in 7.5% SDS-
In diabetic rat kidney cortex, at 24 to 30 weeks ofpolyacrylamide gel electrophoresis (SDS-PAGE) mini-
diabetes, CTGF expression was increased approximatelygels and electroblotted to nitrocellulose. Membranes
2.2-fold compared with controls (N  6; Fig. 1), sug-were blocked and incubated with anti-TSP monoclonal
gesting a potential contribution of this profibrogenicantibody at 1:600 in blocking buffer (Ab-4; Neomarkers,
growth factor to progressive interstitial fibrosis. This cor-Fremont, CA, USA), washed, and incubated with second
related with immunohistological findings. In both controlantibody. Bands were visualized as indicated previously
and diabetic rat kidney, CTGF was found in distal tu-in this article.
bules in the cortex and in medullary and papillary collect-
Quantitative TGF- bioassay ing ducts. In control rat kidney, proximal tubules in the
cortex were negative. In contrast, in diabetic rats, CTGFConditioned media were cleared by centrifugation,
was expressed in some proximal tubules. In experimentaland total TGF- was measured after heating at 80C
diabetic nephropathy, CTGF expression was more intensefor five minutes in a quantitative and highly sensitive
in dilated proximal tubules with hypotrophic-appearingbioassay using mink lung epithelial cells stably trans-
cells (Fig. 2).fected with a truncated plasminogen activator-1 (PAI-1)
promoter/luciferase reporter construct (kindly provided The immunohistologic distribution of IGF-I was re-
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Fig. 3. CTGF mRNA levels in MCT cells incubated with pooled, 1:5-
diluted proximal tubular fluid that was collected by nephron micropunc-
ture from rats after 24 to 30 weeks of diabetes. *P  0.05 compared
with control.
Fig. 5. Western blot analysis of CTGF that has accumulated in medium
in cultured MCT cells incubated with or without TGF-. The addition
of heparin (Hep) to the incubation medium prevents cell surface and
ECM binding of CTGF. *P  0.05 compared with control.
cultured proximal tubular cells. Incubation of serum-
deprived MCT cells with pooled, 1:5-fold diluted early
proximal tubular fluid (N 4) obtained by nephron micro-
puncture from rats at 24 to 30 weeks after the induction
of diabetes caused a small but significant increase in
steady-state CTGF mRNA levels (Fig. 3). Incubation of
serum-deprived MCT cells with rhTGF-1 (1 nmol/L)
increased the expression of CTGF more than twofold
Fig. 4. Effect of rhHGF or rhTGF-1 (each 1 nmol/L) on CTGF (Fig. 4). Recombinant human HGF (1 nmol/L) also in-
mRNA levels in MCT cells. *P  0.05 compared with control.
creased CTGF mRNA levels, albeit to a lesser extent
(Fig. 4). While CTGF mRNA levels in TGF-–stimulated
proximal tubular cells were increased 2.2-fold, levels of
CTGF protein that accumulated in conditioned mediamarkably similar to that of CTGF. Medullary thick as-
over a 48-hour period are increased approximately nine-cending limbs, collecting ducts, and papillary collecting
fold (Fig. 5). Heparin (25 g/mL) increases CTGF levelstubules stained positive for IGF-I in control and diabetic
modestly further under basal conditions as well as duringrat kidneys. In contrast to controls, some proximal tubu-
stimulation with rhTGF-1 (Fig. 5). This latter findinglar cross-sections or individual proximal tubular cells
suggests that only a small aliquot of secreted CTGFstained positive for IGF-I, and dilated proximal tubules
associates with the cell surface or with ECM proteins inwith flattened tubular cells stained more heavily (Fig. 2).
cultured MCT cells.Since proximal tubular cells in diabetic nephropathy
In diabetic nephropathy, tubular cells are exposed, atare exposed to an abnormal glomerular ultrafiltrate con-
least periodically, to a high glucose environment. Totaining ultrafiltered, bioactive HGF and TGF- [3], we
examine the effect of high glucose on CTGF expressionexamined whether early proximal tubular fluid, collected
from diabetic rats, raises the expression of CTGF in in MCTs, cells were incubated with medium containing
Wang et al: CTGF in diabetic nephropathy 101
Fig. 6. Prolonged, 72-hour incubation of proximal tubular cells with high glucose (25 mmol/L) does not increase CTGF and fails to raise TGF-.
(A) CTGF mRNA levels. (B) Representative Western blot of CTGF in media. (C) TGF-1 mRNA levels. (D) TGF- levels in conditioned media
by quantitative bioassay. Abbreviations are: AB, neutralizing anti–TGF- antibody; High glucose, 25 mmol/L.
25 mmol/L glucose for 24 hours (N  6). However, high- diabetic nephropathy. However, tubular epithelial cells
contribute to ECM production, and CTGF secreted byglucose medium does not increase CTGF levels in these
short-term experiments, and coincubation with TGF-- proximal tubular cells may act in an autocrine mode.
Incubation of MCT cells with rhCTGF for 48 hours raisesneutralizing antibodies had no effect (data not shown).
Longer periods of incubation (72 hours) with high glucose fibronectin mRNA levels but not mRNA encoding Col
1III (Fig. 7). Col 2I, which is expressed in MCT cells(25 mmol/L) did also not raise CTGF mRNA expression
in MCT cells or protein levels in conditioned media (Fig. only at very low levels, is also not increased by CTGF
(data not shown).6). In these experiments, high glucose also failed to raise
TGF-1 mRNA, and secreted TGF- peptide levels in In serum-deprived rat renal interstitial fibroblasts
(NRK-49F cells), low concentrations of CTGF (50conditioned media were also unchanged (Fig. 6).
The primary target cells for CTGF in the renal intersti- pmol/L) do not increase mRNA levels encoding fibro-
nectin, Col 2I, or Col 1III (data not shown). Moreover,tium are most likely myofibroblasts, which are also
thought to be the cells most responsible for provid- coincubation with iso-molar rhIGF-I had also no additive
effect on the expression of the two collagen genes. Ining interstitial ECM proteins in interstitial fibrosis of
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Fig. 8. Col 1III mRNA levels in NRK-49F cells incubated with serum-
free medium (control) containing 0.25% fetal calf serum (serum), or
low serum-containing medium in the presence of IGF-I, CTGF, or both
growth factors. *P  0.05 compared with control.
renal interstitial fibroblasts increased thrombospondin
secretion into media, which also was increased further
by rhIGF-I. This latter growth factor itself did not affect
TSP levels (Fig. 9 C, D).
DISCUSSION
In diabetic nephropathy (and in most other chronic,
proteinuric glomerular diseases), renal interstitial fibro-Fig. 7. Fibronectin and col 1III mRNA levels in MCT cells that were
incubated in the presence or absence (control) of CTGF. *P  0.05 sis is a major contributing factor for progressive renal
compared with control. failure [1, 17]. Previous experimental findings have indi-
cated that tubular cells receive signals from bioactive
growth factors (such as HGF, TGF-, IGF-I) that are
translocated into tubular fluid caused by the glomerularserum-deprived NRK-49F fibroblasts at a greater con-
centration (1 nmol/L), rhCTGF also did not increase Col ultrafiltration of plasma proteins [2, 4]. This strategic
localization of tubular cells makes them prone to play a1III expression (Fig. 8). However, coincubation with
rhIGF-I and rhCTGF, each at 1 nmol/L, increased Col major role in initiating and regulating events that lead
to progressive interstitial fibrosis. Ultrafiltered HGF and1III mRNA levels approximately 2.5-fold (Fig. 8). Al-
though rhIGF-I (1 nmol/L) modestly increased the ex- TGF-, which activate tubular cells, contribute to inter-
stitial fibrosis by direct and indirect mechanisms [2, 3].pression of collagen III by itself, the rise in the expression
of col 1III during combined incubation with rhCTGF These include (1) a direct increase in ECM protein ex-
pression by tubular cells, (2) an increase in tubular cellwas more than additive (Fig. 8).
In NRK-49F cells that were infected with adenoCTGF, expression and secretion of C-C-chemokines, which at-
tract and activate macrophages [3], and (3) an increaseCTGF protein levels in conditioned media were elevated
about 26  4-fold. Coincubation of infected cells with in tubular cell expression of platelet-derived growth fac-
tor-B, which is a strong mitogen for interstitial myofi-IGF-I did not affect CTGF levels in control or adeno-
CTGF infected cells (Fig. 9A). Similar to studies provid- broblasts [2].
In cells of mesenchymal derivation, namely smoothing rhCTGF exogenously, endogenous overexpression
of CTGF did not raise Col 2I mRNA levels in NRK- muscle cells, mesangial cells, and (nonrenal) fibroblasts,
CTGF is thought to mediate (some of) the activity of49F cells. Col 1III mRNA levels were moderately but
significantly increased in cells infected with adenoCTGF, TGF- toward increased expression of ECM proteins
by autocrine and likely paracrine action [8, 10, 12]. Inand coincubation with rhIGF-I (50 pmol/L) further aug-
mented the adCTGF-induced rise in Col 1III mRNA such mesenchymal cells, the CTGF gene is regulated by
a specific TGF- response element [7]. Moreover, inlevels (Fig. 9B). Similarly, overexpression of CTGF in
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Fig. 9. (A) NRK-49F renal interstitial fibroblasts overexpressing CTGF by infection with an adenoviral vector. Incubation of control or adCTGF-
infected cells with rhIGF-I (50 pmol/L) does not modify CTGF levels in media (Western blot analysis). (B) Col 1III mRNA levels in control and
adCTGF-infected cells in the presence and absence or rhIGF-I (50 pmol/L). *P  0.05 vs. control; **P  0.08 vs. adCTGF. (C and D) Expression
of thrombospondin by Western blot analysis of media from control and adCTGF-infected NRK-49F cells in the presence or absence of IGF-I (50
pmol/L). *P  0.05 vs. control; **P  0.013 vs. adCTGF. (Note the different order of sample loading in the blots in a and c).
mesangial cells, CTGF expression is up-regulated by high and interstitial fibrosis and, hence, tends to correlate
glucose levels in medium [11, 12]. This function of CTGF with fibrosis [18]. Findings from experimental studies
downstream from TGF- renders this molecule an inter- in nonrenal epithelial cell systems suggest that CTGF
esting target for intervention. expression occurs after or in association with epithelial
Given the apparently important role of tubular cells cell transdifferentiation [19].
in contributing to the development and progression of In cultured tubular cells, CTGF expression is TGF-
renal interstitial fibrosis in diabetic nephropathy, our responsive (Fig. 4). Previously, CTGF was thought to be
studies examined whether proximal tubular cells express TGF- dependent only in mesenchymal, nonepithelial
CTGF, whether this growth factor is regulated by high cell types such as fibroblasts, smooth muscle cells, and
glucose, conditioned glomerular ultrafiltrate, or HGF or mesangial cells. As indicated in Figure 4, TGF-1 in-TGF- in tubular fluid, and whether (tubular cell de-
creases CTGF expression approximately 2.2-fold, whichrived) CTGF may mediate interstitial ECM protein accu-
is less than observed in mesenchymal cells by other inves-mulation.
tigators [7, 12]. In vitro in cultured MCT cells, CTGFIndeed, in experimental diabetic nephropathy in vivo,
substantially accumulates in the media (Fig. 5). Appar-renal cortical expression of CTGF is increased and occurs
ently, the protein is degraded only slowly under currentin some proximal tubules, more so in dilated, hypotro-
cell culture conditions. Moreover, the proportion ofphic tubules (Figs. 1 and 2). In human renal biopsy speci-
CTGF that associates with cell surfaces and ECM ap-men from patients with various glomerular diseases, as
pears to be similar under basal and TGF-–stimulatedwell as with diabetic nephropathy, increased tubulointer-
stitial CTGF tends to localize to areas of tubular atrophy conditions, suggesting that their respective binding sites
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are nearly saturated and do not accommodate much fur- mental diabetic nephropathy [21]. Moreover, TSP-1 acti-
ther binding after stimulation of CTGF secretion. vates TGF- from its latent precursor, suggesting an
In MCT cells, expression of CTGF is also moderately amplifying role of TSP in profibrogenic events [22].
HGF sensitive (Fig. 4). This finding suggests that in prox- Findings in the present studies also indicate that CTGF
imal tubular epithelial cells, CTGF is not specifically and synergizes with IGF-I. Incubation of NRK-49F cells with
exclusively regulated by TGF-. Given that diabetic rat CTGF raises Col 1III expression approximately 2.5-fold
glomerular ultrafiltrate contains bioactive HGF and in the presence of IGF-I and substantially more than
TGF- [2], it is not surprising that incubation of MCT each protein alone. Similar findings were obtained in
cells with pooled diabetic rat early proximal tubular fluid cells endogenously overexpressing CTGF. Kim et al dem-
increases CTGF mRNA levels (Fig. 3). Although the onstrated that CTGF binds IGFs at a specific site [13].
increase in CTGF mRNA in this experiment is rather While an alternative name for CTGF, namely IGF-bind-
modest, it has to be taken into consideration that the ing protein-8, had been suggested, the lesser affinity of
pooled tubular fluid was diluted fivefold prior to assay. the interaction relative to IGFBP-1 to -6 is not consistent
Mesenchymal cells (mesangial cells, fibroblasts) re- with this designation [14]. The binding of IGFs to CTGF
spond to high glucose with increased CTGF expression. may still be of biologic importance since it increases
Some studies suggest that in mesangial cells, this is medi- the bioactivity of CTGF toward Col 1III expression inated by glucose-induced TGF- [12]. However, in the cultured renal interstitial fibroblasts, although the mech-
present studies in proximal tubular cells, CTGF expres- anisms of IGF-I–induced activation of CTGF are un-
sion and secretion are glucose insensitive, and even pro-
known. Moreover, in vivo in diabetic rat kidney, IGF-I
longed incubation with high glucose medium does not
and CTGF tend to be colocalized, which is compatibleincrease CTGF mRNA or secreted peptide (Fig. 6).
with a similar collaboration between the two peptidesRocco et al reported that incubation of MCT cells with
in vivo as shown in the current in vitro experiments.high glucose (25 mmol/L) for 48 hours raises the expres-
In summary, the present experimental studies indicatesion of TGF-1 by 63% [20]. In the present studies, short-
a pathophysiologic role of tubule-derived CTGF to con-term as well as prolonged incubation with high glucose
tribute to interstitial fibrosis mainly (but not exclusively)failed to raise TGF-1 mRNA and secreted cytokine
by acting on interstitial fibroblasts. Proximal tubular epi-levels (Fig. 6 C, D). Reasons for this discrepancy of
thelial cell CTGF is glucose independent but is inducedseemingly similar experimental studies remain unclear.
by TGF- and, surprisingly, also by HGF, as well asTubular cell-derived CTGF may act on the same cell
by diabetic rat glomerular ultrafiltrate (containing bothby autocrine modes and contribute to (TGF-– and
growth factors). IGF-I augments the profibrogenic activ-HGF-induced) increased expression of ECM proteins.
ity of CTGF likely through direct interaction.MCT cells respond to CTGF with an increase in fibro-
nectin expression by 50% but not with a significant rise
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surement of all different collagen proteins independent
Abbreviations used in this article are: BSA, bovine serum albumin;of type and pathophysiologic function (basement mem-
CMV, cytomegalovirus; Col, collagen; CTGF, connective tissue growthbrane vs. interstitial collagen) and may overestimate col- factor; ECM, extracellular matrix; GFP, green fluorescent protein;
lagen amounts, since each protein chain incorporates HGF, hepatocyte growth factor; IGF, insulin-like growth factor; MCT,
mouse proximal convoluted tubules; MOI, multiplicity of infection;many labeled prolines.
PAI, plasminogen activator inhibitor; PBS, phosphate-buffered saline;In cultured renal interstitial fibroblasts, CTGF increases
rh, recombinant human; RT-PCR, reverse transcription-polymerase
TSP-1 secretion. This ECM protein has been found to chain reaction; TBS, Tris-buffered saline; TGF, transforming growth
factor; TSP, thrombospondin.contribute to interstitially accumulating matrix in experi-
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